MedPath

The effect of a single intracavernous injection of autologous adipose-derived stem cells in patients with erectile dysfunctio

Not Applicable
Conditions
Erectile dysfunction
Registration Number
JPRN-UMIN000043103
Lead Sponsor
Al Zahraa Hospital
Brief Summary

Following ADSCs administration, the EF was improved in all patients of the treatment group. One month after therapy, All of the patients in the treatment group had an increase in their IEF-5 score. At 3 and 6 months, in this group, the degree of ED was mild in all patients. In the control group, for patients treated only with PDE5i, the ED remains severe all the time

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

Impotent male before radical cystectomy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assess the erectile function of the study groups: the control group and the treatment group Assess the safety of adipose stem cell in the treatment group
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath